Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
1 study found for:    23432801 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth
Conditions: Malaria;   Sexually Transmitted Diseases;   Preterm Birth;   Pregnancy
Interventions: Drug: Sulfadoxine-pyrimethamine treatment twice during pregnancy;   Drug: Sulfadoxine-pyrimethamine at 4-week intervals;   Drug: Sulfadoxine-pyrimethamine every 4 weeks + azithromycin twice
To Top

† Indicates status has not been verified in more than two years